Literature DB >> 9037177

Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury.

G Ferry1, M Lonchampt, L Pennel, G de Nanteuil, E Canet, G C Tucker.   

Abstract

The effect of neutrophil elastase on the functional status of gelatinases was studied in an hamster model developed by intratracheal administration of lipopolysaccharide followed by in situ cell activation with phorbol myristate acetate. This resulted in the production in bronchoalveolar lavage fluids, in addition to the matrix metalloproteinase MMP-9, of a 75 kDa gelatinase associated with collagenolytic activity. Treatment in vivo with an elastase inhibitor abolished the latter activity. Since, in addition, elastase activates in vitro purified MMP-9 gelatinase into a similar 75 kDa entity, these data suggest that elastase may be a physiological activator of MMP-9 in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9037177     DOI: 10.1016/s0014-5793(96)01508-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  55 in total

1.  Is hormone replacement therapy in post-menopausal women associated with a reduced risk of oesophageal cancer?

Authors:  Shyam Menon; Peter Nightingale; Nigel Trudgill
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

Review 2.  Hematopoietic stem cell homing to injured tissues.

Authors:  Dean Philip John Kavanagh; Neena Kalia
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

Review 3.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

4.  Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.

Authors:  Satish Singh; Aiilyan K Houng; Guy L Reed
Journal:  Neuroscience       Date:  2017-12-30       Impact factor: 3.590

5.  Matrix metalloproteinases production in malignant pleural effusions after talc pleurodesis.

Authors:  P D'Agostino; A Rao Camemi; R Caruso; F Arcoleo; A Cascio; A Dolce; E Sacco; G Cangemi; T di Rosa; P Moceo; E Cillari
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis.

Authors:  Mark Hirsh; Julie Carmel; Viktoria Kaplan; Erella Livne; Michael M Krausz
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

7.  Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.

Authors:  Maria A Nagel; Igor Traktinskiy; Kurt R Stenmark; Maria G Frid; Alexander Choe; Don Gilden
Journal:  Neurology       Date:  2012-12-12       Impact factor: 9.910

8.  Antiproteases as therapeutics to target inflammation in cystic fibrosis.

Authors:  Derek J Quinn; Sinéad Weldon; Clifford C Taggart
Journal:  Open Respir Med J       Date:  2010-03-30

9.  Predominant role of host proteases in myocardial damage associated with infectious endocarditis induced by Enterococcus faecalis in a rat model.

Authors:  Pascal Augustin; Ghada Alsalih; Yoann Launey; Sandrine Delbosc; Liliane Louedec; Véronique Ollivier; Françoise Chau; Philippe Montravers; Xavier Duval; Jean-Baptiste Michel; Olivier Meilhac
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

10.  Characterization of human pre-elafin mutants: full antipeptidase activity is essential to preserve lung tissue integrity in experimental emphysema.

Authors:  Alain Doucet; Dominique Bouchard; Marie France Janelle; Audrey Bellemare; Stéphane Gagné; Guy M Tremblay; Yves Bourbonnais
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.